Neuroendocrine Tumors  >>  Caprelsa (vandetanib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Caprelsa (vandetanib) / Sanofi
NCT00533169: ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma

Terminated
1
10
US
ZD6474, Zactima, Vandetanib, Retinoic Acid, Isotretinoin, Accutane, 13-cis-Retinoic Acid
M.D. Anderson Cancer Center, AstraZeneca
Neuroblastoma
02/11
02/11
NCT01539655: Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib

Completed
1
34
US
vandetanib, omeprazole, ranitidine
Sanofi
Medullary Thyroid Cancer
09/12
09/12
NCT01941849: Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

Withdrawn
1
0
Europe
Vandetanib, Caprelsa, 131I-mIBG, Iodine-131 labelled Meta-iodobenzylguanine
University College, London, Cancer Research UK, AstraZeneca
Phaeochromocytoma, Paraganglioma
12/15
12/15

Download Options